A Study of Zasocitinib (TAK-279) in Adults With Active Crohn's Disease

Clinical trial NCT07403968 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07403968
Sponsor: Takeda
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2026-07-15
Primary completion: 2028-03-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.